Dr. Baker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7831 Chicago Ct
Omaha, NE 68114Phone+1 402-354-1230Fax+1 402-354-1235
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2004
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1999 - 2001
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1998 - 1999
- University of Nebraska College of MedicineClass of 1998
- Nebraska Wesleyan UniversityBS, Biopsychology with Highest Distinction, 1990 - 1994
Certifications & Licensure
- NE State Medical License 2004 - 2026
- MN State Medical License 2001 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012-2013
- American Medical Women’s Association Memorial Achievement Citation 1998
- Alpha Omega Alpha 1997
- Join now to see all
Clinical Trials
- Genetic Study in Patients With Stage II or Stage III Colon Cancer Start of enrollment: 1999 Feb 01
- Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma Start of enrollment: 2000 Jul 04
- Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy Start of enrollment: 1999 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsThe sodium-iodide symporter.Claire H. Baker, John C. Morris
Current Drug Targets. Immune, Endocrine and Metabolic Disorders. 2004-08-31 - 91 citationsInitial segment Kv2.2 channels mediate a slow delayed rectifier and maintain high frequency action potential firing in medial nucleus of the trapezoid body neuronsJamie Johnston, Sarah J. Griffin, Claire A. Baker, Anna E. Skrzypiec, Tatanya Chernova
The Journal of Physiology. 2008-07-15 - 47 citationsA Novel Therapeutic Strategy for Medullary Thyroid Cancer Based on Radioiodine Therapy following Tissue-Specific Sodium Iodide Symporter Gene ExpressionNeziha Cengic, Claire H. Baker, Martin Schütz, Burkhard Göke, John C. Morris
The Journal of Clinical Endocrinology and Metabolism. 2005-08-01
Journal Articles
- Acute Pancreatitis Secondary to Primary Hyperparathyroidism in a Teenager.Laguna LE, Schwartz MJ, van Heerden JA, Baker CH, Contemporary Surgery
- A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.Cengic N, Baker CH, Schütz M, Göke B, Morris JC, Spitzweg C, Journal of Clinical Endocrinology and Metabolism
- Radiodiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C, Gene Therapy
- Join now to see all
Abstracts/Posters
- A Case of Malignant Struma Ovarii.Baker CH, Gharib H, 5th Mayo Clinic Endocrine Course, Grand Bahama Island, Bahamas
- A Case of Primary Hyperparathyroidism Associated with Nephrocalcinosis, Brown Tumors, and Pancreatitis in an Adolescent.Baker CH, Laguna LE, Schwartz MJ, Casey MB, van Heerden JA, Rizza RA, The American Association of Clinical Endocrinologists 11th Annual Meeting, Chicago, Illinois
- The Mayo Clinic Experience with Pituitary Incidentaloma.Baker CH, Erickson BJ, Young WF, Vella A, The Endocrine Society’s 85th Annual Meeting, Philadelphia, Pennsylvania
- Join now to see all
Lectures
- The effects of liraglutide versus placebo when added to basal insulin analogues with or without meformin in subjects with type 2 diabetes.Novo Nordisk Pharmaceuticals
- A randomized, multicenter, double-blind, parallel, placeblo-controlled study of the effects of JNJ-28431754 on cardiovascular outcomes in adult subjects with type 2 di...Johnson & Johnson Pharmaceutical Research & Development
- Comparison of glycemice control in obese subjects with diabetes using the BD Ultra-Fine Nano 4mmx32G pen needle, and either the BD Ultra Fine Short 8mmx31G pen needle ...BD Medical – Diabetes Care
- Join now to see all
Press Mentions
- How Menstrual Cups Are Changing People's PeriodsJune 22nd, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: